AIRLINK 187.09 Increased By ▲ 2.40 (1.3%)
BOP 12.69 Decreased By ▼ -0.09 (-0.7%)
CNERGY 7.58 Decreased By ▼ -0.23 (-2.94%)
FCCL 40.42 Decreased By ▼ -0.42 (-1.03%)
FFL 14.86 Decreased By ▼ -0.32 (-2.11%)
FLYNG 27.36 Increased By ▲ 0.42 (1.56%)
HUBC 131.21 Increased By ▲ 0.14 (0.11%)
HUMNL 13.26 Decreased By ▼ -0.56 (-4.05%)
KEL 4.45 Decreased By ▼ -0.06 (-1.33%)
KOSM 6.01 Decreased By ▼ -0.13 (-2.12%)
MLCF 53.16 Increased By ▲ 1.93 (3.77%)
OGDC 212.59 Increased By ▲ 0.48 (0.23%)
PACE 6.06 Decreased By ▼ -0.23 (-3.66%)
PAEL 41.94 Decreased By ▼ -0.61 (-1.43%)
PIAHCLA 15.93 Decreased By ▼ -0.58 (-3.51%)
PIBTL 9.60 Increased By ▲ 0.66 (7.38%)
POWER 11.16 Increased By ▲ 0.06 (0.54%)
PPL 173.29 Decreased By ▼ -1.71 (-0.98%)
PRL 34.13 Decreased By ▼ -0.60 (-1.73%)
PTC 23.47 Decreased By ▼ -0.47 (-1.96%)
SEARL 88.09 Decreased By ▼ -6.33 (-6.7%)
SILK 1.11 Decreased By ▼ -0.03 (-2.63%)
SSGC 32.61 Decreased By ▼ -0.50 (-1.51%)
SYM 15.53 Decreased By ▼ -1.58 (-9.23%)
TELE 7.99 Decreased By ▼ -0.26 (-3.15%)
TPLP 11.00 Decreased By ▼ -0.45 (-3.93%)
TRG 59.79 Decreased By ▼ -0.46 (-0.76%)
WAVESAPP 11.28 Decreased By ▼ -0.11 (-0.97%)
WTL 1.41 Decreased By ▼ -0.04 (-2.76%)
YOUW 3.81 Decreased By ▼ -0.12 (-3.05%)
AIRLINK 187.09 Increased By ▲ 2.40 (1.3%)
BOP 12.69 Decreased By ▼ -0.09 (-0.7%)
CNERGY 7.58 Decreased By ▼ -0.23 (-2.94%)
FCCL 40.42 Decreased By ▼ -0.42 (-1.03%)
FFL 14.86 Decreased By ▼ -0.32 (-2.11%)
FLYNG 27.36 Increased By ▲ 0.42 (1.56%)
HUBC 131.21 Increased By ▲ 0.14 (0.11%)
HUMNL 13.26 Decreased By ▼ -0.56 (-4.05%)
KEL 4.45 Decreased By ▼ -0.06 (-1.33%)
KOSM 6.01 Decreased By ▼ -0.13 (-2.12%)
MLCF 53.16 Increased By ▲ 1.93 (3.77%)
OGDC 212.59 Increased By ▲ 0.48 (0.23%)
PACE 6.06 Decreased By ▼ -0.23 (-3.66%)
PAEL 41.94 Decreased By ▼ -0.61 (-1.43%)
PIAHCLA 15.93 Decreased By ▼ -0.58 (-3.51%)
PIBTL 9.60 Increased By ▲ 0.66 (7.38%)
POWER 11.16 Increased By ▲ 0.06 (0.54%)
PPL 173.29 Decreased By ▼ -1.71 (-0.98%)
PRL 34.13 Decreased By ▼ -0.60 (-1.73%)
PTC 23.47 Decreased By ▼ -0.47 (-1.96%)
SEARL 88.09 Decreased By ▼ -6.33 (-6.7%)
SILK 1.11 Decreased By ▼ -0.03 (-2.63%)
SSGC 32.61 Decreased By ▼ -0.50 (-1.51%)
SYM 15.53 Decreased By ▼ -1.58 (-9.23%)
TELE 7.99 Decreased By ▼ -0.26 (-3.15%)
TPLP 11.00 Decreased By ▼ -0.45 (-3.93%)
TRG 59.79 Decreased By ▼ -0.46 (-0.76%)
WAVESAPP 11.28 Decreased By ▼ -0.11 (-0.97%)
WTL 1.41 Decreased By ▼ -0.04 (-2.76%)
YOUW 3.81 Decreased By ▼ -0.12 (-3.05%)
BR100 11,869 Decreased By -51.1 (-0.43%)
BR30 35,588 Decreased By -219.5 (-0.61%)
KSE100 113,252 Decreased By -532.6 (-0.47%)
KSE30 35,194 Decreased By -193.2 (-0.55%)

dechra-pharmaceuticalsLONDON: Britain's Dechra Pharmaceuticals posted a 15 percent rise in full-year profit, helped by a strong performance from its branded products, and said it would invest in developing its range for dogs, cats and horses.

"Although footfall through veterinary practices has declined and the general economic climate remains uncertain we are continuing to demonstrate solid growth in markets in which we trade," the company said in a statement on Tuesday.

"Our branded product range, the focus of our key strategic objective, continues to grow strongly."

The company, which develops prescription medicines for dogs, cats and horses, therapeutic diets for dogs and cats, and unlicensed medicines, shampoos and supplements, posted underlying pretax profit of 30.1 million pounds ($48.5 million) on revenue 5.4 percent higher at 389.2 million pounds.

Dechra said it had increased investment in product development and moved into new geographies to continue growth.

It is increasing its final dividend for the year to end-June to 8.4 pence a share, up from 7.25 pence a year ago.

Copyright Reuters, 2011

Comments

Comments are closed.